Global DNA Methylation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global DNA Methylation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
DNA methylation is an epigenetic mechanism that occurs by the addition of a methyl (CH3) group to DNA, thereby often modifying the function of the genes and affecting gene expression. The most widely characterized DNA methylation process is the covalent addition of the methyl group at the 5-carbon of the cytosine ring resulting in 5-methylcytosine (5-mC), also informally known as the “fifth base” of DNA. These methyl groups project into the major groove of DNA and inhibit transcription.
DNA Methylation report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global DNA Methylation market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Pharmaceutical and Biotechnology Companies and Research and Academic Institutions are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for DNA Methylation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, DNA Methylation key companies include Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck Group, Pacific Biosciences of California, Inc. and PerkinElmer, Inc., etc. Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc. are top 3 players and held % share in total in 2023.
DNA Methylation can be divided into Consumables, Instruments and Software Tools,, etc. Consumables is the mainstream product in the market, accounting for % share globally in 2023.
DNA Methylation is widely used in various fields, such as Pharmaceutical and Biotechnology Companies, Research and Academic Institutions, Contract Research Organizations (CROs) and Others, etc. Pharmaceutical and Biotechnology Companies provides greatest supports to the DNA Methylation industry development. In 2023, global % share of DNA Methylation went into Pharmaceutical and Biotechnology Companies filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global DNA Methylation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Abcam plc
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Exact Sciences Corporation
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Merck Group
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Active Motif, Inc.
Diagenode Diagnostics SA
EpiGentek Group Inc.
New England Biolabs, Inc.
Zymo Research Corporation
Segment by Type
Consumables
Instruments
Software Tools
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Contract Research Organizations (CROs)
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the DNA Methylation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, DNA Methylation introduction, etc. DNA Methylation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of DNA Methylation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
DNA Methylation report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global DNA Methylation market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Pharmaceutical and Biotechnology Companies and Research and Academic Institutions are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for DNA Methylation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, DNA Methylation key companies include Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck Group, Pacific Biosciences of California, Inc. and PerkinElmer, Inc., etc. Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc. are top 3 players and held % share in total in 2023.
DNA Methylation can be divided into Consumables, Instruments and Software Tools,, etc. Consumables is the mainstream product in the market, accounting for % share globally in 2023.
DNA Methylation is widely used in various fields, such as Pharmaceutical and Biotechnology Companies, Research and Academic Institutions, Contract Research Organizations (CROs) and Others, etc. Pharmaceutical and Biotechnology Companies provides greatest supports to the DNA Methylation industry development. In 2023, global % share of DNA Methylation went into Pharmaceutical and Biotechnology Companies filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global DNA Methylation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Abcam plc
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Exact Sciences Corporation
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Merck Group
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Active Motif, Inc.
Diagenode Diagnostics SA
EpiGentek Group Inc.
New England Biolabs, Inc.
Zymo Research Corporation
Segment by Type
Consumables
Instruments
Software Tools
Segment by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Contract Research Organizations (CROs)
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the DNA Methylation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, DNA Methylation introduction, etc. DNA Methylation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of DNA Methylation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices